Literature DB >> 27666129

Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespan.

Jin-Shei Lai1,2,3, Sally E Jensen1,4, Zabin S Patel1, Robert Listernick2,3, Joel Charrow2,3.   

Abstract

Neurofibromatosis Type 1 (NF1) plexiform neurofibromas (pNFs) are associated with a variety of symptoms and concerns that affect patients' quality of life (QOL), highlighting the value of incorporating the patients' perspective when evaluating treatment outcomes. To better conceptualize the experience of patients with pNFs, this qualitative study sought to identify the most important outcomes to assess from the perspective of patients, families, and clinicians. Clinicians, patients age 5 years old and above, and parents of patients aged 5-17 years participated in semi-structured interviews to elicit the pNF symptoms/concerns considered most important to assess. The data were analyzed using an iterative coding procedure and the frequency with which symptoms/concerns emerged was tabulated. Eight clinicians, 31 patients, and 17 parents of patients participated in semi-structured interviews. The most frequently reported concerns raised by patients across all age groups included pain, appearance/disfigurement, social activity/role participation, stigma, and anxiety. For parents, physical functioning was the primary concern, followed by pain, social activity/role participation, appearance/disfigurement, and social relationships. The resulting conceptual framework included five domains to represent the most important identified symptoms/concerns: pain, social functioning, physical function impact, stigma, and emotional distress. This conceptual framework describing the symptoms/concerns of patients with pNF can help investigators create a measurement system to improve assessment of aspects of QOL only patients can report on. It may also provide the ability to identify symptoms/concerns that might warrant referrals to various clinical disciplines.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  lifespan; neurofibromatosis type 1; patient-centered outcomes; plexiform neurofibromas

Mesh:

Year:  2016        PMID: 27666129     DOI: 10.1002/ajmg.a.37987

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Proposed domains for assessing postpartum recovery: a concept elicitation study.

Authors:  P Sultan; S E Jensen; J Taylor; Y El-Sayed; S Carmichael; D Cella; M S Angst; B Gaudilliere; D J Lyell; B Carvalho
Journal:  BJOG       Date:  2021-10-14       Impact factor: 7.331

2.  Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood.

Authors:  Sally E Jensen; Zabin S Patel; Robert Listernick; Joel Charrow; Jin-Shei Lai
Journal:  J Clin Psychol Med Settings       Date:  2019-09

3.  Worries and needs of adults and parents of adults with neurofibromatosis type 1.

Authors:  Andre B Rietman; Hanneke van Helden; Pauline H Both; Walter Taal; Jeroen S Legerstee; AnneLoes van Staa; Henriette A Moll; Rianne Oostenbrink; Agnies M van Eeghen
Journal:  Am J Med Genet A       Date:  2018-05       Impact factor: 2.802

4.  Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.

Authors:  Akram Sanagoo; Leila Jouybari; Fatemeh Koohi; Fatemeh Sayehmiri
Journal:  BMC Neurol       Date:  2019-06-12       Impact factor: 2.474

5.  Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA.

Authors:  Xiaoqin Yang; Hyun Kyoo Yoo; Suvina Amin; Wendy Y Cheng; Sanjana Sundaresan; Lujia Zhang; Mei Sheng Duh
Journal:  Childs Nerv Syst       Date:  2022-05-17       Impact factor: 1.532

Review 6.  Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review.

Authors:  Catherine Copley-Merriman; Xiaoqin Yang; Melissa Juniper; Suvina Amin; Hyun Kyoo Yoo; Shuvayu S Sen
Journal:  Adolesc Health Med Ther       Date:  2021-05-19

Review 7.  Spectrum of gastrointestinal lesions of neurofibromatosis type 1: a pictorial review.

Authors:  Nada Garrouche; Amel Ben Abdallah; Nadia Arifa; Ibtissem Hasni; Yasser Ben Cheikh; Waad Ben Farhat; Sana Ben Amor; Hela Jemni
Journal:  Insights Imaging       Date:  2018-09-04

8.  A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.

Authors:  Alice Heaney; Jeanette Wilburn; Shannon Langmead; Jaishri Blakeley; Susan Huson; Carly Jim; Stephen P McKenna
Journal:  SAGE Open Med       Date:  2019-02-11

9.  The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.

Authors:  Alice Heaney; Jeanette Wilburn; Matthew Rouse; Shannon Langmead; Jaishri O Blakeley; Susan Huson; Stephen P McKenna
Journal:  Mol Genet Genomic Med       Date:  2020-10-21       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.